Molecular association of ZBTB11 in schizophrenia

Molecular mechanism exploration and clinical correlation of transcription factor ZBTB11 and programmed cell death in schizophrenia

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500097910

Enrollment

Unknown

Registered

2025-02-27

Start date

2024-04-01

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Control Group:None

Schizophrenia group:None

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age: 18-65 years old; 2.Race: Han ethnicity; 3.Diagnosis: Meets the diagnostic criteria for schizophrenia in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) of the United States; 4.Voluntarily participate in this study, and I or my guardian sign an informed consent form;

Exclusion criteria

Exclusion criteria: 1.Individuals with organic brain diseases, neurological disorders, and severe endocrine or metabolic disorders; 2.Individuals with other DSM-IV axis I and II diseases (such as mood disorders, substance related disorders, mental retardation, etc.); 3.For those who do not meet the author's requirements for examination or treatment, or are unable to effectively complete the examination and treatment;

Design outcomes

Primary

Measure	Time frame
ZBTB11 expression in peripheral blood;Target gene expression;	—

Countries

China

Contacts

Public ContactJing Shen

Jiangsu Shengze Hospital

165344440@qq.com+86 512 63097185

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026